First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?

Volume 20, Issue 1, December 2024 .

Source: Human Vaccines and Immunotherapeutics - February 25, 2024 Category: Allergy & Immunology Authors: Dimitrios BouzianasStella Bouzianaa BReMeL, Biopharmaceutical and Regenerative Medicine Laboratories, Thessaloniki, Greeceb Department of Hematology, King ’s College Hospital, London, UK Source Type: research